Investor Relations

$25,000,000 Investment Opportunity

2,500,000 Units          $10/Units          $15,000 Minimum

                            Invest in Panda Biotech -- a Dallas-based company whose management team has

                         successfully completed infrastructure transactions totaling $12 billion -- that intends to

                         develop the largest Hemp Gins in the U.S. to process textile-grade, cottonized fiber. 

                         Panda Biotech will create high-demand/high-value hemp fiber for domestic and global

                         export from American-grown industrial hemp, the most sustainable crop on the planet.

Bringing Grown and Sewn Back to the USA


                            If you would like to know more about the current investment opportunity with

                         Panda Biotech, please fill out the Investor Request Form below and an executive with

                         Panda Biotech will respond.  


                         Investor Qualifications:  In order to invest in Panda Biotech, a person needs to qualify as

                         an Accredited Investor, as defined in Regulation D under the Securities Act of 1933 .  

                         The two methods of qualifying as an individual “accredited investor” are as follows: 

                         (i) a person whose individual net worth, or joint net worth with that of their spouse,

                         exceeds $1,000,000 (excluding the value of his/her/their primary residence) or  (ii)  a 

                         person who had an individual income in excess of $200,000 in each of the two most

                         recent years or had joint income with their spouse in excess of $300,000 in each of

                         those years, and has a reasonable expectation of reaching the same income level in the

                         current year.



Investor Request Form

All Fields Required

  • Instagram
  • Twitter
  • LinkedIn Social Icon

©2019-2020  by Panda Biotech, LLC.